PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $48.6 million in its fourth quarter.

The Pleasanton, California-based company said it had a loss of 41 cents per share.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share.

The life science technology company posted revenue of $184 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected $183.9 million.

For the year, the company reported a loss of $255.1 million, or $2.18 per share. Revenue was reported as $618.7 million.

10x Genomics expects full-year revenue in the range of $670 million to $690 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News